Medical Letter on the CDC & FDA articles from December 2004

Medical Letter on the CDC & FDA archives from December 2004

Providers in Brazil following guidelines for management of HIV patients.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Providers in Rio de Janeiro, Brazil, are following national guidelines for the management of HIV-infected patients on antiretroviral therapy. According to recent research from the United States and...

Blood samples from fatal and nonfatal cases of Ebola infection analyzed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have analyzed human peripheral blood samples from fatal and nonfatal cases of Ebola hemorrhagic fever. "Peripheral blood samples obtained from patients during an outbreak of Ebola virus...

Metabolite of pesticide methoxychlor reduces testosterone formation.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The active metabolite of the pesticide methoxychlor, 2,2-bis(P-hydroxyphenyl)-1,1,1-trichloroethane, significantly reduces testosterone formation. "Methoxychlor (MC) is an insecticide that is...

Outbreak of hepatitis B in drug users causes high mortality.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- An outbreak of acute hepatitis B among injection drug users caused fulminant liver failure resulting in high mortality. "Death related to acute hepatitis B occurs in approximately 1% of patients....

Internet Alert Project spreads word about high-risk sexual activities.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The Internet Alert Project is spreading the word about high-risk sexual activities advertised on the Internet. According to a study from the United States, "The Internet is an emerging venue for...

Model of perinatal transmission of SHIV in macaques developed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have developed a model of the perinatal transmission of SHIV-SF162P3 in Macaca nemestrina. "We developed a SHIV/macaque model of transmission from infected dams to their infants. Ten...

HIV-1 Tat protein modulates generation of cytotoxic T cell epitopes.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. According to a study from Italy, "Tat, the trans activation...

HIV-1 Tat vaccine protects against SHIV89.6P replication in monkeys.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat vaccinated cynomolgus monkeys were protected against SHIV89.6P replication. According to a study from Italy, "Vaccination with a biologically active Tat protein or tat DNA contained...

nef-deleted SHIV protects against pathogenic virus infection.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A nef-deleted simian and human immunodeficiency virus (SHIV) protected against pathogenic virus infection. According to published research from Japan, "To clarify the involvement of primitive...

U.S. FDA approves Evoclin for treating acne.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Connetics Corp. (CNCT), a specialty-pharmaceutical company that develops and commercializes dermatology products, announced that the U.S. Food and Drug Administration (FDA) has approved Evoclin...

Pharma company files amendment for urine NTP test kit.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced that it has filed an amendment to its premarket approval application (PMA) for the company's urine NTP test kit with the U.S. Food and Drug...

Plasmid DNA vaccine protects against aerosolized anthrax spores.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. According to a study from the United States, "DNA vaccines provide...

Vaccine protects cheetah and black rhinoceros against anthrax.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers have developed a vaccine that protects cheetahs and rhinoceroses against anthrax. According to a study from England, Namibia, and the United States, "Institution of a policy of...

Antibiotics use alliance report reveals urgency of drug resistance worldwide.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A new report released at a meeting of the American Society for Microbiology describes the ominous presence of disease-causing micro-organisms resistant to today's front-line drugs. "Shadow...

CryoBlator approved for use in U.S. trials, CE marked in Europe.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- CryoCor, Inc., a development-stage medical technology company, announced that it has received U.S. Food and Drug Administration approval to use its Model 1200 (CryoBlator) series of cardiac catheters in...

Data shows Tamiflu is effective against human H5N1 and avian H5N1 influenza.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- New data presented confirms that oseltamivir (Tamiflu), an oral neuraminidase inhibitor (NAI), is effective against the human H5N1 and avian H5N1 influenza virus. Since the influenza virus is...

Indian Salmonella Typhi isolates have reduced ciprofloxacin susceptibility.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Salmonella Typhi isolates in India have reduced susceptibility to ciprofloxacin. "Typhoid fever continues to remain a health problem as the causative organism Salmonella Typhi has developed...

High-throughput method for counting bacterial colonies developed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have developed a method for high-throughput imaging of bacterial colonies grown on 96-well filter plates. "The ability to accurately enumerate viable bacteria has applications in...

Basal cell carcinoma rates continuously increasing in the Netherlands since 1973.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Basal cell carcinoma rates have been continuously increasing in the Netherlands since 1973. "This study is aimed to determine the characteristics of the trends in incidence of basal cell carcinoma...

FDA grants priority review status for brain tumor drug; EMEA application made.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corporation (SGP) reported that the U.S. Food and Drug Administration (FDA) has granted 6-month priority review status to its supplemental new drug application (sNDA) for Temodar...

Femara gets U.S. FDA nod as post-tamoxifen treatment for early breast cancer.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Femara (letrozole tablets) is the first therapy approved by the U.S. Food and Drug Administration for the extended adjuvant treatment of postmenopausal women with early breast cancer who have received...

New breast exam recommendations issued.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A new report published by the American Cancer Society recommends training healthcare providers in a standardized version of clinical breast exam to find palpable cancers. The Breast Health...

Connective tissue disorder risk in breast implant patients re-assessed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have re-assessed the risk of connective tissue disorders in breast implant patients. "In a U.S. retrospective cohort study (1960-1996), 351 (4.8%) of 7,234 patients with breast implants...

System lowers breast augmentation re-operation rate by 17%.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Plastic surgeons can reduce breast implant re-operations in augmentation patients to 3% by following a new system of decision and management algorithms, according to a new report. At the same time,...

Medical oncology device company announces third quarter, 9-month results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- RITA Medical Systems, Inc., (NASDAQ:RITA) announced that sales for the third quarter ended September 30, 2004, were $8.0 million, with a net loss of $3.3 million, or $0.10 loss per share, compared to...

Pharma company offers data on Yondelis and Aplidin at conference.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- PharmaMar presented new data from its two lead drugs, Yondelis and Aplidin, at the 29th European Society for Medical Oncology Congress (ESMO) held in Vienna, Austria. Data from two separate studies...

Company achieves commercial scale of antigen for Provenge.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Dendreon Corp. (DNDN) announced that it has succeeded in reproducing the antigen used in the preparation of Provenge, the company's investigational immunotherapy for the treatment of prostate cancer, at...

U.S. FDA fast-tracks phenoxodiol for recurrent ovarian cancer.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Marshall Edwards, Inc., (MSHL) announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anticancer drug, phenoxodiol, fast track status for its intended use in patients...

DNA vaccine protects against lethal canine distemper virus challenge.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Immunization with plasmid DNA encoding the hemagglutinin and the nucleoprotein confers robust protection against a lethal canine distemper virus challenge. According to recent research from Denmark...

African American heart failure trial data submitted to the U.S. FDA.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- NitroMed, Inc., (NASDAQ: NTMD) announced that it has submitted the African American Heart Failure Trial (A-HeFT) clinical dataset to the U.S. Food and Drug Administration (FDA). This submission is...

Pharma company granted rights to thrombolytic agent, names executives.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Nuvelo, Inc., (Nasdaq: NUVO) announced that it will gain worldwide rights to develop and commercialize the novel acting thrombolytic agent, alfimeprase, from Amgen Inc. in exchange for payment of...

Stem cell focused biotech completes equity financing to support clinical trial.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- StemCells, Inc. (STEM) has consummated the private placement of 7,500,000 shares of its registered common stock at a purchase price of $3.00 per share, for gross proceeds to StemCells, Inc. of $22.5...

Low levels of cigarette smoke induce irreversible change in cell chromosomes.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Low levels of cigarette smoke induce irreversible change in cell chromosomes. "Exposure to cigarette smoke has long been linked to carcinogenesis, but the emphasis has been placed on mutational...

New data from hyponatremia treatment trials released.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Yamanouchi Pharma America, Inc., a subsidiary of Yamanouchi Pharmaceutical Co., Ltd., announced that its investigational drug, conivaptan hydrochloride, produced significant increases in serum sodium...

NDA for anticancer therapeutic drug submitted to U.S. FDA by two drug companies.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc. (SUPG) and MGI Pharma Inc. (MOGN) announced that the full new drug application (NDA) seeking approval of Dacogen (decitabine) for injection has been submitted to the U.S. Food and Drug...

U.S. FDA clears second stage of CoFactor phase II trial.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- ADVENTRX Pharmaceuticals, Inc., (ANX) announced that it has been granted allowance by the U.S. Food and Drug Administration (FDA) to begin recruiting patients for the second stage of its phase II trial...

Risk of community-associated MRSA infection is associated with several factors.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The risk of acquiring community-associated methicillin-resistant Staphylococcus aureus infection is associated with several factors. According to a study from the United States, "An outbreak of...

Direct smear rapid/effective for diagnosis of Cyclospora cayetanensis infection.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The direct smear method is rapid and effective for the diagnosis of Cyclospora cayetanensis infection. "Cyclospora cayetanensis oocysts in the feces of humans from Kathmandu, Nepal were identified...

T cell immunity to cytomegalovirus studied in HIV patients after HAART.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers have assessed human cytomegalovirus-specific T cell immunity in HIV-infected patients in different disease stages following HAART and in long-term non-progressors. "T cell immunity to...

Mutations in dengue virus vaccine candidate decreases virus replication.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining...

Developmental toxicity of water disinfection by-products appears to be additive.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- In an investigation of the developmental toxicity of mixtures, researchers have reported on the water disinfection by-products dichloro-, dibromo- and bromochloro acetic acid in rat embryo culture. ...

U.S. FDA gives nod to OTC use of insulin-dosing technology.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Dimensional Dosing Systems, Inc., announced that the company has received FDA (U.S. Food and Drug Administration) approval for over the counter (OTC) patient use of the company's insulin-dosing...

Method to measure perchlorate anion in foods by IC-MSMS developed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have developed a method to measure perchlorate anion in foods using ion chromatography-tandem mass spectrometry (IC-MSMS). According to a study from the United States, "A rapid,...

Whole blood cytokine detection assay to quantitate T-cells developed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have developed a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. According to recent research from the United States and South...

Diarrhea episodes in slum area of north Jakarta, Indonesia, studied.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have investigated diarrhea episodes and treatment-seeking behavior in a slum area of north Jakarta, Indonesia. According to a study from Jakarta and South Korea, "Visits to household...

Preferences for treatment of diarrhea in China surveyed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have surveyed preferences for treatment of diarrhea and dysentery in Zhengding county, Hebei province, China. According to a study from South Korea, China, and Switzerland, "Passive...

Self-treatment for diarrhea common in Vietnam.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Self-treatment for diarrhea is common in Vietnam. "To better understand healthcare use for diarrhea and dysentery in Nha Trang, Vietnam, qualitative interviews with community residents and...

Cultural context of dysentery has implications for vaccine introduction.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The cultural and social contexts of dysentery have implications for the introduction of a new vaccine. "Dysentery, a severe form of diarrheal disease, is a major cause of morbidity and mortality....

Influence of method and operator on Elispot results reviewed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists review the influence of method and operator on the variability of Elispot assays in a recent issue of the Journal of Immunological Methods. "In this study, a comprehensive comparative...

PillCam reported as accurate as EGD in visualizing esophagus abnormalities.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Given Imaging (GIVN) announced the complete data from a study of PillCam ESO in the detection of abnormalities of the esophagus in patients with gastroesophageal reflux disease (GERD), presented at the...

EPA seeks applicants for grants to investigate environmentally induced disease.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- To improve the health and well-being of children, the U.S. Environmental Protection Agency's (EPA's) Assistant Administrator for Research and Development Dr. Paul Gilman announced that EPA is soliciting...

Medical technology company granted marketing clearance for Lasik technology.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Norwood Abbey Limited (OTC: NABYY)(OTC: NABYF)(ASX: NAL) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance for the company's new 9.0mm version of the...

Biopharmaceutical company reports loss of $0.22 per share.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) reported financial results for the 3 and 9 months ended September 30, 2004. For the 3 months ended September 30, 2004, the company reported a net loss of $8.7 million or...

Medical imaging company reports $2.6 million loss in third quarter.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- DOBI Medical International, Inc., (DBMI.OB) announced its financial results for the third fiscal quarter of 2004, ended September 30, 2004. The net loss for the third quarter of 2004 was...

Oncology-focused pharmaceutical co. reports third quarter financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Sonus Pharmaceuticals, Inc. (SNUS) reported third quarter financial results and updated its progress on corporate initiatives, including the clinical and regulatory development of Tocosol Paclitaxel....

Ophthalmic products producer reports improved third quarter financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- STAAR Surgical company (NASDAQ:STAA) announced financial results for its third quarter of 2004, which ended October 1, 2004. Total product sales for the third quarter were $12,141,000 compared with...

Pharma company announces improved third quarter 2004 financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc. (PDL) (Nasdaq: PDLI) reported a net loss of $13.6 million, or $0.14 per basic and diluted share, for the 3 months ended September 30, 2004, compared with a net loss of $18.9...

Pharmaceutical company announces revenues of $1M due to Plenaxis sales.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) announced consolidated financial results for the 3 and 9 months ended September 30, 2004. The company's net loss for the 3 months ended September...

Vision technology firm raises $9M, obtains protocol agreement for MelaFind.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Electro-Optical Sciences, Inc., (EOS) a company in the field of medical computer vision technology, announces the closing of a $9 million extension of its series C preferred financing. In addition,...

Biopharma company initiates phase II trial with TB4 for chronic pressure ulcers.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- RegeneRx Biopharmaceuticals, Inc., (OTCBB:RGRX) announced that it received no objections from U.S. Food and Drug Administration (FDA) within the statutory 30-day comment period and will initiate its...

Clinical trial results of nocturnal gastric acidity drugs comparison reported.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Santarus, Inc. (SNTS), a pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, announced results of a clinical trial comparing the effects of Zegerid immediate-release...

Generic drug maker announces tentative approval of restosterone gel 1%.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Par Pharmaceutical Companies, Inc., (NYSE:PRX) announced that its partner, Paddock Laboratories, has been granted tentative approval by the U.S. Food and Drug Administration (FDA) for its abbreviated...

U.S. FDA approves ANDA for Citalopram hydrobromide tablets.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Dr. Reddy's Laboratories (RDY) announced that the U. S. Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Citalopram...

New indication for Norditropin approved by FDA.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved the use of Norditropin (somatropin [rDNA] injection) in adults with severe growth hormone deficiency. ...

Pharma company files application with FDA for antiretroviral agent.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Ranbaxy Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL had filed an ANDA with the U.S. Food and Drug Administration (FDA) for Zidovudine Tablets, 300 mg. ...

Strategy developed to decrease global burden of TB/HIV.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- According to recent guidelines published in the European Respiratory Journal, "Tuberculosis (TB) in Europe is declining in countries in western and central Europe, but the burden is still high and...

Rapid field test sensitive and specific for detecting/differentiating HIV types.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A rapid field test is sensitive and specific for the detection and differentiation of HIV types 1 and 2. "We evaluated a two-rapid-test serial algorithm using the Determine and Genie 11 rapid...

WHO issues new online tool kit for sex workers.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The German technical cooperation (GTZ) and the World Health Organization (WHO), in collaboration with sex work networks around the world, are launching the first-ever online tool kit aimed at helping...

Molecular makeup of HIV-1 envelope protein described.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists describe the molecular makeup of the HIV-1 envelope protein in a recent issue of International Reviews of Immunology. According to recent research from Yugoslavia, "A broad range of...

State of the art in AIDS vaccines reviewed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers review the state of the art in AIDS vaccines in a recent issue of International Reviews of Immunology. According to a study from Yugoslavia, "This overview briefly summarizes the...

VIP/NTM-reactive natural antibodies applied to HIV infection therapy.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers have applied VIP/NTM-reactive natural antibodies to HIV infection therapy. "In sera of HIV-infected individuals natural antibodies recognizing nonimmunogenic C-terminal domain of the...

HHS approves Idaho request to help SCHIP families buy employer-based insurance.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The U.S. Department of Health and Human Services (HHS) has approved Idaho's request to help families of children in the State Children's Health Insurance Program (SCHIP) buy health insurance through...

Britain should adopt universal hepatitis B immunization, says doctor.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Britain should adopt universal hepatitis B immunization, says a senior doctor. The United Kingdom is one of the few developed countries that have not implemented universal immunization. Because the...

European authorities give positive opinion for Fendrix vaccine.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Further to the filing for regulatory approval with the European Agency for the Evaluation of Medicinal Products (EMEA) in May 2003, GlaxoSmithKline Biologicals (GSK Bio) has received a positive opinion...

Trials show hepatitis B agent a statistical improvement in infected patients.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Data were presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) regarding investigational hepatitis B agent from Bristol-Myers Squibb Company (BMY)....

Peginterferon alfa-2B studies show positive data in treatment of hepatitis C.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C were presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD)....

Pre-IND contact initiated with U.S. FDA for clinical trials of CY301 for herpes.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- CytoGenix, Inc., (CYGX) announced that it has submitted a pre-investigational new drug (IND) brief and has initiated discussions with the FDA (U.S. Food and Drug Administration) Center for Drug...

Structure of anti-human immunodeficiency virus type 1 antibody 2F5 reported.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers report results of a structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope in a recent issue of the Journal of...

Financial challenges of immunization reviewed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Investigators review the financial challenges of immunization programs in a recent issue of the Bulletin of the World Health Organization. "Securing reliable and adequate public funding for...

U.S. FDA clears new Equinoxe shoulder system.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Exactech, Inc., (EXAC) announced that the company's new Equinoxe shoulder system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The Equinoxe Shoulder System...

Economics of infectious disease eradication versus control reviewed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A researcher reviews the economics of infectious disease eradication versus control in a recent issue of the Bulletin of the World Health Organization. "A disease is controlled if, by means of a...

CDC and states announce plan to distribute 10.3 million flu shots nationwide.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Working closely with public health officials nationwide, the U.S. Centers for Disease Control and Prevention (CDC) announced plans to distribute the remaining 10.3 million doses of Aventis Pasteur...

CDC to include FluMist in vaccines for children program.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that FluMist (Influenza Virus Vaccine Live, Intranasal) has been included in the federal government's Vaccines for Children (VFC) program as an alternative to the...

Flu preparedness must become public health priority.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Influenza experts at a Pan American Health Organization technical meeting said that national preparedness plans to confront a potential influenza pandemic must become a "public health priority without...